Short and Long-Term Effects of hVEGF-A₁₆₅ in Cre-Activated Transgenic Mice

• Pia Leppänen,

  Affiliation Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland

  ⨯
• Ivana Kholová,

  Affiliation Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland

  ⨯
• Anssi J. Mähönen,

  Affiliation Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland

  ⨯
• Kari Airenne,

  Affiliation Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland

  ⨯
• Suvi Koota,

  Affiliation Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland

  ⨯
• Hannu Mansukoski,

  Affiliation Technical University of Dresden, Dresden, Germany

  ⨯
• Johanna Närväinen,

  Affiliation Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom

  ⨯
• Maria Wirzenius,

  Affiliation Molecular/Cancer Biology Laboratory, Biomedicum, University of Helsinki, Helsinki, Finland

  ⨯
• Leena Alhonen,

  Affiliation Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland

  ⨯
• Juhani Jänne,

  Affiliation Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland

  ⨯
• Kari Alitalo,

  Affiliation Molecular/Cancer Biology Laboratory, Biomedicum, University of Helsinki, Helsinki, Finland

  ⨯
• Seppo Ylä-Herttuala

  *To whom correspondence should be addressed. E-mail: Seppo.Ylaherttuala@uku.fi

  Affiliations Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland, Department of Medicine and the Gene Therapy Unit, Kuopio University Hospital, Kuopio, Finland

  ⨯